An­oth­er biotech CEO de­parts, leav­ing be­hind few em­ploy­ees for PhI­II

A month af­ter lay­ing off 20% of its em­ploy­ees, Pal­isade Bio’s CEO is al­so out the door. Thomas Hal­lam hit the ex­it on Mon­day and fi­nance chief JD Fin­ley took over as in­ter­im CEO.

The gas­troin­testi­nal-fo­cused biotech dis­closed the de­par­ture Tues­day morn­ing with­out of­fer­ing any de­tails on why Hal­lam’s nine-year tenure con­clud­ed, or where the out­go­ing CEO might be head­ed. He joined as a VP in 2014 fol­low­ing a di­rec­tor stint at Mesoblast and took over the top spot at Pal­isade in 2017.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER